Evaluation of the Effects of a Combination of Vitamin C, Thiamine and Hydrocortisone vs Hydrocortisone Alone on ICU Outcome in Patients with Septic Shock: A Randomized Controlled Trial.

Sachit Sharma, Hem R Paneru, Gentle S Shrestha, Pramesh S Shrestha, Subhash P Acharya
Author Information
  1. Sachit Sharma: Department of Critical Care Medicine, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Bagmati, Nepal. ORCID
  2. Hem R Paneru: Department of Critical Care Medicine, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Bagmati, Nepal. ORCID
  3. Gentle S Shrestha: Department of Critical Care Medicine, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Bagmati, Nepal. ORCID
  4. Pramesh S Shrestha: Department of Critical Care Medicine, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Bagmati, Nepal. ORCID
  5. Subhash P Acharya: Department of Critical Care Medicine, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Bagmati, Nepal. ORCID

Abstract

Aims and background: Glucocorticoids, vitamin C and thiamine have important biological effects in patients with sepsis and septic shock. Multiple studies have demonstrated the beneficial role of a combination therapy of vitamin C, hydrocortisone and thiamine in patients with sepsis and septic shock in terms of mortality reduction, and increase in the number of days free of ventilators and vasopressors.
Materials and methods: Patients who had septic shock were assessed for eligibility after intensive care unit (ICU) admission. After randomization, the treatment group received a combination of vitamin C, thiamine and hydrocortisone for a duration of 96 hours (16 doses) and the control group received hydrocortisone for a duration till the patient was on vasopressors. The primary outcome assessed was ICU mortality, and the key secondary outcome was the duration free of vasopressor administration at the end of 7 days.
Results: A total of 86 patients were included in the study. Seventy percent of patients in the control group and 58 percent in the intervention group died during ICU stay. None of the primary and secondary outcomes were statistically significant.
Conclusion: The use of a combination of vitamin C, hydrocortisone and thiamine has no added benefits over the use of hydrocortisone alone in patients with septic shock.
Clinical significance: The results of this clinical trial shows that the use of a combination of vitamin C, hydrocortisone and thiamine in patients with septic shock is not useful and should not be a routine practice in critically ill septic patients.
How to cite this article: Sharma S, Paneru HR, Shrestha GS, Shrestha PS, Acharya SP. Evaluation of the Effects of a Combination of Vitamin C, Thiamine and Hydrocortisone vs Hydrocortisone Alone on ICU Outcome in Patients with Septic Shock: A Randomized Controlled Trial. Indian J Crit Care Med 2024;28(12):1147-1152.

Keywords

References

  1. N Engl J Med. 2000 May 4;342(18):1301-8 [PMID: 10793162]
  2. N Engl J Med. 2008 Jan 10;358(2):111-24 [PMID: 18184957]
  3. JAMA. 2014 Apr 2;311(13):1308-16 [PMID: 24638143]
  4. N Engl J Med. 2018 Mar 01;378(9):797-808 [PMID: 29347874]
  5. Indian J Crit Care Med. 2020 Aug;24(8):649-652 [PMID: 33024369]
  6. Crit Care Med. 2007 Nov;35(11):2568-75 [PMID: 17901831]
  7. Chest. 2017 Jun;151(6):1229-1238 [PMID: 27940189]
  8. JAMA. 2017 Oct 3;318(13):1241-1249 [PMID: 28903154]
  9. Am J Respir Cell Mol Biol. 2012 Jul;47(1):60-6 [PMID: 22343220]
  10. Crit Care. 2004 Aug;8(4):R251-60 [PMID: 15312226]
  11. Crit Care Med. 2013 Dec;41(12):2770-2 [PMID: 23989175]
  12. JAMA. 2016 Feb 23;315(8):801-10 [PMID: 26903338]
  13. Indian J Crit Care Med. 2020 Aug;24(8):653-661 [PMID: 33024370]
  14. Lancet. 2010 Oct 16;376(9749):1339-46 [PMID: 20934212]
  15. JAMA. 2021 Feb 23;325(8):742-750 [PMID: 33620405]
  16. Crit Care Med. 2013 Feb;41(2):580-637 [PMID: 23353941]
  17. Crit Care Med. 2015 Feb;43(2):288-95 [PMID: 25599463]
  18. Chest. 2011 Nov;140(5):1223-1231 [PMID: 21852297]
  19. JAMA. 2019 Oct 1;322(13):1261-1270 [PMID: 31573637]
  20. Intensive Care Med. 2017 Mar;43(3):304-377 [PMID: 28101605]
  21. JAMA. 2020 Feb 4;323(5):423-431 [PMID: 31950979]
  22. Chest. 2017 Feb;151(2):278-285 [PMID: 27452768]

Word Cloud

Created with Highcharts 10.0.0CpatientssepticshockhydrocortisonevitaminthiamineICUHydrocortisonecombinationgroupPatientsdurationuseVitaminThiamineSepticsepsismortalitydaysfreevasopressorsassessedcareunitreceivedcontrolprimaryoutcomesecondarypercentShresthaEvaluationEffectsCombinationvsAloneOutcomeShock:RandomizedControlledTrialAimsbackground:GlucocorticoidsimportantbiologicaleffectsMultiplestudiesdemonstratedbeneficialroletherapytermsreductionincreasenumberventilatorsMaterialsmethods:eligibilityintensiveadmissionrandomizationtreatment96hours16dosestillpatientkeyvasopressoradministrationend7Results:total86includedstudySeventy58interventiondiedstayNoneoutcomesstatisticallysignificantConclusion:addedbenefitsaloneClinicalsignificance:resultsclinicaltrialshowsusefulroutinepracticecriticallyillHowcitearticle:SharmaSPaneruHRGSPSAcharyaSPIndianJCritCareMed20242812:1147-1152IntensiveVasopressors

Similar Articles

Cited By (1)